Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Arch Cardiovasc Dis ; 116(1): 33-40, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36526570

ABSTRACT

BACKGROUND: The prevalence and significance of abnormal epicardial coronary vasomotor reactivity (ACVR) in patients with symptoms compatible with myocardial ischaemia remains ill-defined. Our diagnostic strategy is to perform a provocative test (PT) in every patient presenting with chest pain at rest, for whom coronary angiography does not reveal significant epicardial coronary artery disease (≥70% stenosis by visual assessment). AIM: To evaluate such a strategy in terms of incidence of ACVR, PT safety and patient outcomes. METHODS: The present study was a retrospective observational study with a median clinical follow-up of 5years. The primary outcome was incidence of ACVR in patients with PT. Risk factors for ACVR and clinical follow-up were obtained, and the rate of major adverse cardiovascular and cerebrovascular events (MACCE; death, cardiovascular mortality, myocardial infarction, stroke and coronary revascularization) was reported. RESULTS: ACVR was documented in 294 (12.4%) of the 2379 patients with PT, out of the 13,654 patients undergoing angiography. Patients with ACVR were more often female (43.9% vs. 30.0%; P<0.0001), current smokers (37.4% vs. 8.7%; P<0.0001) and had a suspected acute coronary syndrome (36.7% vs. 29.1%; P=0.005) at admittance compared with patients without ACVR. During clinical follow-up, MACCE occurred more frequently in patients with (9.8%) than in those without (3.7%) ACVR (hazard ratio [HR] 4.15, 95% confidence interval [CI] 2.62-6.57; P<0.0001), including more myocardial infarctions (4.0% vs. 0.4%; HR 17.8, 95% CI 6.41-49.5; P<0.0001) and more myocardial revascularizations (6.1% vs. 1.1%; HR 9.36, 95% CI 4.67-18.74; P<0.0001) compared with patients with normal PT at baseline. CONCLUSIONS: ACVR is frequent in patients with symptoms compatible with myocardial ischaemia at rest, with no significant coronary stenosis. PT is a safe strategy to identify a population at high risk of recurrent ischaemic events.


Subject(s)
Coronary Artery Disease , Myocardial Infarction , Myocardial Ischemia , Percutaneous Coronary Intervention , Humans , Female , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/therapy , Coronary Angiography , Risk Factors , Treatment Outcome
2.
JACC Case Rep ; 3(18): 1906-1910, 2021 Dec 15.
Article in English | MEDLINE | ID: mdl-34984350

ABSTRACT

We describe the case of simultaneous acute thrombotic occlusions in 2 major coronary arteries in a young patient admitted for extensive myocardial infarction. We highlight the importance of intravascular imaging to determine the underlying putative mechanism and to optimize treatment decisions. (Level of Difficulty: Intermediate.).

3.
Am Heart J ; 223: 113-119, 2020 05.
Article in English | MEDLINE | ID: mdl-32087878

ABSTRACT

BACKGOUND: Performing functional testing (FT) or a computed tomography angiogram (CCTA) before invasive coronary angiogram (ICA) is recommended for coronary artery disease (CAD). We aimed to evaluate, in a real life setting, the rate of strictly normal ICA following a positive noninvasive test result. METHODS: We included all patients who underwent an ICA with a prior positive FT or CCTA. Patients were categorized in 5 subgroups, according to pretest probability (PTP) of having a CAD. Main results of ICA were defined as normal ICA, nonobstructive CAD (non-oCAD), and obstructive CAD (oCAD). RESULTS: For 4,952 patients who underwent ICA following either a positive FT (3276, 66.2%) or CCTA (1676, 33.8%) result, the PTP was (1) low (<15%; n = 968, 19.5%), (2) lower intermediate (15%-35%; n = 1336, 27.0%), (3) higher intermediate (35%-50%; n = 806, 16.3%), (4) high (50%-65%; n = 806, 17.7%), and (5) very high (> 65%; n = 965, 19.5%). ICA showed no CAD (819 patients, 16.5%), non-oCAD (1,193 patients, 24.1%), or oCAD (2940 patients, 59.4%). Without considering the PTP values, CCTA compared to FT showed less frequently normal ICA (7% vs 16.5%), and more frequently CAD (non-oCAD 27.9% vs 22.2%; oCAD 65.1% vs 56.4%) (all P < .0001). When we considered the different PTP values, CCTA always showed lower rates of normal ICA than the FT. In low- and lower intermediate-risk patients, CCTA detected more frequently oCAD compared to FT (P < .001). CONCLUSIONS: CCTA is a better alternative than FT to limit unnecessary ICA regardless of PTP value, without missing abnormal ICA.


Subject(s)
Computed Tomography Angiography , Coronary Angiography/methods , Coronary Artery Disease/diagnostic imaging , Aged , Coronary Angiography/statistics & numerical data , Female , Humans , Male , Middle Aged , Retrospective Studies
5.
Catheter Cardiovasc Interv ; 84(5): 766-71, 2014 Nov 01.
Article in English | MEDLINE | ID: mdl-23982995

ABSTRACT

AIMS: To compare the efficacy of three vasodilators in preventing radial artery spasm (RAS) in patients undergoing transradial percutaneous coronary interventions (PCI). METHODS AND RESULTS: 731 patients were randomized to receive diltiazem 5 mg, verapamil 2.5 mg, or isosorbide dinitrate (ISDN) 1 mg before coronary intervention. RAS occurred in 20.1% in the whole population and was significantly reduced by verapamil and ISDN compared to diltiazem (16.2, 17.2, and 26.6%, respectively; P < 0.006). There was also a trend towards less severe pain (more than 8 on a numerical scale from 0 [no pain] to 10 [maximal pain]), and less severe RAS (complete catheter blockage or severe pain), among patients treated by verapamil compared to ISDN and diltiazem (1.3% vs. 2.8% vs. 2.9%, P = 0.43 and 5.1% vs. 6.2% vs. 9.5%, respectively, P = 0.13). No difference was found between the three vasodilators in terms of crossover or safety events. Female gender, failure at first attempt to access the radial artery, emergency procedures, and the use of diltiazem were independent predictors of RAS. CONCLUSION: Verapamil and ISDN considerably reduce the incidence of RAS compared to diltiazem during transradial PCI.


Subject(s)
Angioplasty, Balloon, Coronary/methods , Diltiazem/administration & dosage , Isosorbide Dinitrate/administration & dosage , Radial Artery/drug effects , Spasm/prevention & control , Verapamil/administration & dosage , Aged , Analysis of Variance , Cardiac Catheterization/methods , Coronary Angiography , Coronary Stenosis/diagnostic imaging , Coronary Stenosis/therapy , Female , Follow-Up Studies , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Prospective Studies , Treatment Outcome , Vasoconstriction/drug effects , Vasodilator Agents/administration & dosage
6.
Arch Cardiovasc Dis ; 102(11): 749-54, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19944390

ABSTRACT

BACKGROUND: Operator radiation exposure is high during coronary procedures. The radial access decreases the rate of local vascular complications but increases operator radiation exposure. As the X-ray exposure is related to the distance between the operator and the radiation source, the use of an extension tube between the proximal part of the coronary catheter and the 'injection device' might decrease operator radiation exposure. AIMS: To demonstrate that the use of an extension tube during coronary procedures performed through the radial approach decreases operator radiation. METHODS: Overall, 230 patients were included consecutively and randomized to procedures performed with or without an extension tube. Radiation exposure measures were obtained using two electronic dosimeters, one under the lead apron and the other exposed on the physician's left arm. RESULTS: A non-significant trend towards lower left-arm operator exposure was noted in the extension tube group (28.7+/-31.0microSv vs 38.4+/-44.2microSv, p=0.0739). No significant difference was noted according to the type of procedure. Radiation levels were low compared with the series published previously and decreased for each operator during the study. CONCLUSION: The use of an extension tube did not reduce operator radiation exposure during procedures performed through the radial approach. However, physician awareness was increased during the study due to the use of an exposed electronic dosimeter. The use of exposed electronic dosimeters could therefore be recommended to allow operators to improve their protection techniques.


Subject(s)
Angioplasty, Balloon, Coronary/instrumentation , Coronary Angiography/instrumentation , Occupational Diseases/prevention & control , Occupational Exposure , Occupational Health , Radial Artery/diagnostic imaging , Radiation Injuries/prevention & control , Radiation Protection , Radiography, Interventional/instrumentation , Aged , Angioplasty, Balloon, Coronary/adverse effects , Attitude of Health Personnel , Awareness , Coronary Angiography/adverse effects , Equipment Design , Female , Health Knowledge, Attitudes, Practice , Humans , Male , Middle Aged , Occupational Diseases/etiology , Prospective Studies , Radiation Dosage , Radiation Injuries/etiology , Radiation Monitoring , Radiography, Interventional/adverse effects , Time Factors
7.
Catheter Cardiovasc Interv ; 68(2): 231-5, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16819768

ABSTRACT

AIMS: Radial artery spasm remains the major limitation of transradial approach for percutaneous coronary interventions. The aim of our study was to evaluate the efficacy of vasodilators in the prevention of radial artery spasm during percutaneous coronary interventions. METHODS AND RESULTS: 1,219 patients were consecutively randomized to receive placebo (n = 198), molsidomine 1 mg (n = 203), verapamil 2.5 mg (n = 409), 5 mg (n = 203) or verapamil 2.5 mg and molsidomine 1 mg (n = 206). All drugs were administered through the arterial sheath. The primary end point was the occurrence of a radial artery spasm defined by the operator as severe limitation of the catheter movement, with or without angiographic confirmation. Main characteristics including age, sex, wrist and arterial sheath diameters and procedure duration were identical across the groups. The rate of radial artery spasm was lowest in patients receiving verapamil and molsidomine (4.9%), compared to verapamil 2.5 mg or 5 mg (8.3 and 7.9%), or molsidomine 1 mg (13.3%); and placebo (22.2%) (P < 0.0001). CONCLUSION: Radial artery spasm during transradial percutaneous interventions was effectively prevented by the administration of vasodilators. The combination of verapamil 2.5 mg and molsidomine 1 mg provided the strongest relative risk reduction of spasm compared to placebo and should therefore be recommended during percutaneous coronary interventions through the radial approach.


Subject(s)
Angioplasty, Balloon, Coronary , Coronary Vasospasm/prevention & control , Molsidomine/therapeutic use , Vasodilator Agents/therapeutic use , Verapamil/therapeutic use , Aged , Angioplasty, Balloon, Coronary/adverse effects , Coronary Vasospasm/etiology , Double-Blind Method , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Radial Artery
8.
Am J Cardiol ; 94(12): 1543-7, 2004 Dec 15.
Article in English | MEDLINE | ID: mdl-15589013

ABSTRACT

This prospective, multicenter, observational study was designed to assess the in-hospital prognostic importance of renal insufficiency among patients presenting with acute coronary syndrome (ACS). One third of patients with ACS presented with renal insufficiency. After adjustment for potential confounders, decreasing renal function was independently associated with in-hospital death, bleeding, and contrast-induced nephropathy.


Subject(s)
Coronary Disease/complications , Renal Insufficiency/mortality , Contrast Media/adverse effects , Coronary Disease/mortality , Coronary Disease/therapy , Female , Humans , Male , Middle Aged , Prognosis , Prospective Studies , Renal Insufficiency/chemically induced , Renal Insufficiency/etiology , Syndrome
10.
Int J Radiat Oncol Biol Phys ; 58(1): 259-66, 2004 Jan 01.
Article in English | MEDLINE | ID: mdl-14697447

ABSTRACT

PURPOSE: To determine the nature of the changes of the vascular wall after intravascular brachytherapy in stented arteries leading to incomplete stent apposition. METHODS AND MATERIALS: Stents were implanted in the infrarenal aortas of rabbits, and gamma-intravascular brachytherapy (18 Gy) or a sham radiation procedure was immediately implemented. The arteries were harvested at 6 months for histologic analyses. RESULTS: The external elastic lamina area, as well as the vascular wall area behind the stent, were significantly greater in irradiated vs. control arteries (8.94 +/- 0.68 mm2 vs. 6.87 +/- 0.40 mm2 [p <0.001] and 1.56 +/- 0.13 mm2 vs. 0.72 +/- 0.07 mm2 [p <0.001], respectively). The ratio of the intimal area behind the stent related to the total intimal area was greater in the irradiated segments (control vs. irradiated: 9.0% +/- 5.9% vs. 55.3% +/- 15.5%, p <0.05). Neointimal growth of the irradiated vessels outside the stent was characterized by marked fibrin depositions and an inflammatory response around the stent struts. CONCLUSION: Our study revealed the presence of a neointimal layer specifically located behind the stent, which represented the result of an unhealed fibrin-rich tissue growth process 6 months after intravascular brachytherapy.


Subject(s)
Brachytherapy/adverse effects , Stents , Tunica Intima/radiation effects , Animals , Aorta, Abdominal/radiation effects , Constriction, Pathologic/etiology , Gamma Rays , Male , Rabbits , Tunica Intima/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL